ArticleFrontiers in immunology2024

A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses.

James Tristan Gordy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.